UnitedHealth Group (NYSE:UNH) Stock Rating Upgraded by StockNews.com

UnitedHealth Group (NYSE:UNHGet Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.

UNH has been the subject of a number of other research reports. Royal Bank of Canada lowered their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price for the company in a report on Wednesday, June 5th. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a report on Thursday, May 30th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Finally, Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $579.74.

Get Our Latest Report on UNH

UnitedHealth Group Price Performance

NYSE:UNH traded up $8.84 during mid-day trading on Wednesday, reaching $500.95. The stock had a trading volume of 3,189,499 shares, compared to its average volume of 4,247,307. The stock has a market capitalization of $461.07 billion, a P/E ratio of 30.62, a P/E/G ratio of 1.44 and a beta of 0.60. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. UnitedHealth Group has a one year low of $436.38 and a one year high of $554.70. The firm has a 50 day moving average price of $498.98 and a two-hundred day moving average price of $500.02.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.26 EPS. As a group, analysts expect that UnitedHealth Group will post 27.55 earnings per share for the current year.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently modified their holdings of UNH. Norges Bank purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $5,802,231,000. International Assets Investment Management LLC lifted its stake in UnitedHealth Group by 53,573.1% during the fourth quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after purchasing an additional 2,348,107 shares during the last quarter. Swedbank AB acquired a new position in shares of UnitedHealth Group in the 1st quarter valued at $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its stake in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after acquiring an additional 1,196,758 shares in the last quarter. Finally, Jennison Associates LLC lifted its holdings in shares of UnitedHealth Group by 49.3% in the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock valued at $1,904,670,000 after purchasing an additional 1,195,352 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.